Alejandra Leivas

868 total citations
28 papers, 634 citations indexed

About

Alejandra Leivas is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Alejandra Leivas has authored 28 papers receiving a total of 634 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Immunology, 19 papers in Oncology and 8 papers in Molecular Biology. Recurrent topics in Alejandra Leivas's work include Immune Cell Function and Interaction (19 papers), CAR-T cell therapy research (18 papers) and Immunotherapy and Immune Responses (5 papers). Alejandra Leivas is often cited by papers focused on Immune Cell Function and Interaction (19 papers), CAR-T cell therapy research (18 papers) and Immunotherapy and Immune Responses (5 papers). Alejandra Leivas collaborates with scholars based in Spain, United States and France. Alejandra Leivas's co-authors include Joaquín Martínez‐López, Lucía Fernández, Antonio Pérez‐Martínez, Antonio Valeri, Paula Rı́o, Almudena García-Ortiz, Adela Escudero, María Vela, Laura Córdoba and Juan Manuel Torres and has published in prestigious journals such as Blood, PLoS ONE and Scientific Reports.

In The Last Decade

Alejandra Leivas

26 papers receiving 622 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alejandra Leivas Spain 12 439 423 145 133 70 28 634
Michaël Loschi France 12 335 0.8× 166 0.4× 217 1.5× 88 0.7× 35 0.5× 37 626
Danice Wilkins United States 10 345 0.8× 177 0.4× 120 0.8× 86 0.6× 22 0.3× 14 518
Bela Mehta United States 6 506 1.2× 341 0.8× 63 0.4× 99 0.7× 31 0.4× 7 603
Huanle Gong China 11 423 1.0× 178 0.4× 104 0.7× 74 0.6× 26 0.4× 19 543
Tainá Gomes Brazil 9 276 0.6× 71 0.2× 227 1.6× 45 0.3× 32 0.5× 13 493
Nadine Pouw Netherlands 10 286 0.7× 407 1.0× 132 0.9× 14 0.1× 208 3.0× 20 560
Yuka Igarashi Japan 13 256 0.6× 169 0.4× 161 1.1× 28 0.2× 51 0.7× 30 551
Cathelijn E.M. Aarts Netherlands 8 279 0.6× 67 0.2× 166 1.1× 53 0.4× 36 0.5× 16 453
Linda A. Battiato United States 5 333 0.8× 377 0.9× 161 1.1× 22 0.2× 90 1.3× 6 632
Éva Karászi Hungary 8 70 0.2× 142 0.3× 205 1.4× 78 0.6× 53 0.8× 17 389

Countries citing papers authored by Alejandra Leivas

Since Specialization
Citations

This map shows the geographic impact of Alejandra Leivas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alejandra Leivas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alejandra Leivas more than expected).

Fields of papers citing papers by Alejandra Leivas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alejandra Leivas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alejandra Leivas. The network helps show where Alejandra Leivas may publish in the future.

Co-authorship network of co-authors of Alejandra Leivas

This figure shows the co-authorship network connecting the top 25 collaborators of Alejandra Leivas. A scholar is included among the top collaborators of Alejandra Leivas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alejandra Leivas. Alejandra Leivas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Aparicio, Cristina, Antonio Valeri, Alejandra Leivas, et al.. (2025). A Novel Early Memory-Enriched Allogeneic NKG2D CAR-T Cell Therapy Based on CRISPR/Cas9 Technology for Solid Tumors. Cancers. 17(19). 3186–3186.
2.
Carreño‐Tarragona, Gonzalo, María Tiana, Alejandra Leivas, et al.. (2025). The JAK2 46/1 haplotype influences PD-L1 expression. Blood. 145(19). 2196–2201.
3.
Castellano, Eva, Almudena García-Ortiz, Jessica Encinas, et al.. (2024). CRISPR/Cas9 Multi-Editing Enhances CAR NK Cells Therapeutic Potential Against Multiple Myeloma. Blood. 144(Supplement 1). 3442–3442. 3 indexed citations
4.
Escudero, Adela, Gloria Esteso, Carmen Campos‐Silva, et al.. (2023). NKG2D-CAR memory T cells target pediatric T-cell acute lymphoblastic leukemia in vitro and in vivo but fail to eliminate leukemia initiating cells. Frontiers in Immunology. 14. 1187665–1187665. 10 indexed citations
5.
Encinas, Jessica, Almudena García-Ortiz, Eva Castellano, et al.. (2023). S256: HLA-E/NKG2A CHECKPOINT DRIVES MULTIPLE MYELOMA RESISTANCE TO CAR-NK THERAPY. HemaSphere. 7(S3). e16745e9–e16745e9. 2 indexed citations
6.
García‐Ríos, Estéfani, Alejandra Leivas, Francisco J. Mancebo, et al.. (2022). Isolation of Functional SARS-CoV-2 Antigen-Specific T-Cells with Specific Viral Cytotoxic Activity for Adoptive Therapy of COVID-19. Biomedicines. 10(3). 630–630. 1 indexed citations
7.
Linares, María, María Luz Morales, Sophie Allain‐Maillet, et al.. (2022). Efficacy of Antiviral Treatment in Hepatitis C Virus (HCV)-Driven Monoclonal Gammopathies Including Myeloma. Frontiers in Immunology. 12. 797209–797209. 6 indexed citations
8.
Valeri, Antonio, Almudena García-Ortiz, Eva Castellano, et al.. (2022). Overcoming tumor resistance mechanisms in CAR-NK cell therapy. Frontiers in Immunology. 13. 953849–953849. 64 indexed citations
9.
Ortega‐Hernández, Adriana, Alejandra Leivas, Antonio Valeri, et al.. (2022). P1430: GUT MICROBIOTA DIVERSITY AND BUTYRATE PRODUCERS IMPACTS ON NON-HODGKIN LYMPHOMA PATIENTS RESPONSE TO CD19 CAR-T THERAPY. HemaSphere. 6. 1313–1314. 1 indexed citations
10.
Leivas, Alejandra, Antonio Valeri, Laura Córdoba, et al.. (2021). NKG2D-CAR-transduced natural killer cells efficiently target multiple myeloma. Blood Cancer Journal. 11(8). 146–146. 106 indexed citations
11.
Fernández, Lucía, Isabel Mirones, Adela Escudero, et al.. (2019). GMP-Compliant Manufacturing of NKG2D CAR Memory T Cells Using CliniMACS Prodigy. Frontiers in Immunology. 10. 2361–2361. 45 indexed citations
12.
Morales, María Luz, Alejandra Leivas, Inmaculada Rapado, et al.. (2019). MEK inhibition enhances the response to tyrosine kinase inhibitors in acute myeloid leukemia. Scientific Reports. 9(1). 18630–18630. 24 indexed citations
13.
Leivas, Alejandra, Laura Córdoba, Antonio Valeri, et al.. (2019). NKG2D CAR-Expressing Lymphocytes Target Acute Myeloid Leukemia Cells. Blood. 134(Supplement_1). 2667–2667. 1 indexed citations
14.
Leivas, Alejandra, Paula Rı́o, Almudena García-Ortiz, et al.. (2018). NKG2D-CAR Transduced Primary Natural Killer Cells Efficiently Target Multiple Myeloma Cells. Blood. 132(Supplement 1). 590–590. 24 indexed citations
15.
Vela, María, Paula Carrasco, Lucía Fernández, et al.. (2018). Haploidentical IL-15/41BBL activated and expanded natural killer cell infusion therapy after salvage chemotherapy in children with relapsed and refractory leukemia. Cancer Letters. 422. 107–117. 49 indexed citations
16.
Fernández, Lucía, Alejandra Leivas, Jaime Valentín, et al.. (2018). How do we manufacture clinical‐grade interleukin‐15–stimulated natural killer cell products for cancer treatment?. Transfusion. 58(6). 1340–1347. 12 indexed citations
17.
Fernández, Lucía, Adela Escudero, María Vela, et al.. (2017). Memory T Cells Expressing an NKG2D-CAR Efficiently Target Osteosarcoma Cells. Clinical Cancer Research. 23(19). 5824–5835. 83 indexed citations
18.
Leivas, Alejandra, Antonio Valeri, Paula Rı́o, et al.. (2017). Activated and Expanded Natural Killer Cells Expressing an NKG2D-CAR Efficiently Target Multiple Myeloma Cells. Blood. 130. 4466–4466. 6 indexed citations
19.
Leivas, Alejandra, Antonio Pérez‐Martínez, María Jesús Blanchard, et al.. (2016). Novel treatment strategy with autologous activated and expanded natural killer cells plus anti-myeloma drugs for multiple myeloma. OncoImmunology. 5(12). e1250051–e1250051. 70 indexed citations
20.
Vallejo, Susana, Tania Romacho, Javier Angulo, et al.. (2011). Visfatin Impairs Endothelium-Dependent Relaxation in Rat and Human Mesenteric Microvessels through Nicotinamide Phosphoribosyltransferase Activity. PLoS ONE. 6(11). e27299–e27299. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Michaël Loschi Breakdown of academic impact, for papers by Danice Wilkins Breakdown of academic impact, for papers by Bela Mehta Breakdown of academic impact, for papers by Huanle Gong Breakdown of academic impact, for papers by Tainá Gomes Breakdown of academic impact, for papers by Nadine Pouw Breakdown of academic impact, for papers by Yuka Igarashi Breakdown of academic impact, for papers by Cathelijn E.M. Aarts Breakdown of academic impact, for papers by Linda A. Battiato Breakdown of academic impact, for papers by Éva Karászi
Rankless by CCL
2026